Aileron Therapeutics Inc. (ALRN)
NASDAQ: ALRN
· Real-Time Price · USD
2.11
0.18 (9.33%)
At close: Jan 10, 2025, 10:00 PM
Aileron Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.00 | -2.04 | -0.28 | -3.28 | -1.56 | -1.71 | -0.5 | -0.94 | -1.14 | -0.31 | -0.61 | -0.74 | -0.74 | -1.38 | -1.87 | -3.44 | -4.97 | -4.27 |
PEG Ratio | -0.00 | 0.02 | -0.00 | 0.08 | 0.03 | 0.04 | -0.00 | -0.37 | 0.02 | -0.1 | 0.02 | 0.04 | 0.13 | -0.06 | -1.39 | -0.2 | 0.20 | 0.11 |
PS Ratio | n/a | n/a | 361.45 | n/a | n/a | n/a | 108.56 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.00 | 0.90 | 0.84 | 1.53 | 0.55 | 0.53 | 2.11 | 0.62 | 0.64 | 0.39 | 0.58 | 0.83 | 0.83 | 1.29 | 1.16 | 1.84 | 2.01 | 1.94 |
P/FCF Ratio | -0.01 | -7.28 | -9.46 | -20.08 | -6.65 | -9.23 | -1.4 | -4.21 | -2.61 | -1.21 | -2.44 | -2.7 | -4.15 | -5.95 | -8.15 | -12.71 | -29.52 | -18.17 |
P/OCF Ratio | -0.01 | -7.28 | -9.46 | -20.08 | -6.65 | -9.23 | -1.4 | -4.21 | -2.61 | -1.21 | -2.44 | -2.7 | -4.15 | -5.95 | -8.15 | -12.72 | -30.05 | -18.41 |
OCF/S Ratio | n/a | n/a | -38.19 | n/a | n/a | n/a | -77.54 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | 13.28 | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Quick Ratio | 0.86 | 1.39 | 2.38 | 3.30 | 4.69 | 2.82 | 4.17 | 7.88 | 11.66 | 5.93 | 6.46 | 5.96 | 6.51 | 9.65 | 10.69 | 11.93 | 14.08 | 20.93 |
Current Ratio | 0.86 | 1.39 | 2.38 | 3.30 | 4.69 | 2.82 | 4.17 | 7.88 | 11.66 | 5.93 | 6.46 | 5.96 | 6.51 | 9.65 | 10.69 | 11.93 | 14.08 | 20.93 |
Asset Turnover | n/a | n/a | 0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.14 | -0.11 | -0.75 | -0.12 | -0.09 | -0.08 | -1.07 | -0.16 | -0.14 | -0.32 | -0.24 | -0.28 | -0.28 | -0.23 | -0.15 | -0.13 | -0.1 | -0.11 |
Return on Assets | -0.12 | -0.1 | -0.66 | -0.06 | -0.08 | -0.07 | -0.06 | -0.14 | -0.13 | -0.27 | -0.2 | -0.23 | -0.24 | -0.21 | -0.14 | -0.12 | -0.09 | -0.11 |
Return on Invested Capital | -0.14 | -0.11 | -0.76 | -0.06 | -0.09 | -0.08 | -0.07 | -0.18 | -0.16 | -0.33 | -0.24 | -0.28 | -0.28 | -0.23 | -0.15 | -0.13 | -0.11 | -0.11 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | 0.61 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -325.25 | n/a | n/a | n/a | -54.77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -325.25 | n/a | n/a | n/a | -54.77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -339.66 | n/a | n/a | n/a | -54.49 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -325.28 | n/a | n/a | n/a | -54.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |